Literature DB >> 19496385

Evaluation and management of the patient with difficult-to-control or resistant hypertension.

Anthony J Viera1, Alan L Hinderliter.   

Abstract

High blood pressure is often difficult to control. Resistant hypertension is blood pressure above goal despite adherence to a combination of at least three antihypertensive medications of different classes, optimally dosed and usually including a diuretic. The approach to blood pressure that is apparently difficult to control begins with an assessment of the patient's adherence to the management plan, including lifestyle modifications and medications. White-coat hypertension may need to be ruled out. Suboptimal therapy is the most common reason for failure to reach the blood pressure goal. Once-daily fixed-dose combination pills may improve control through the synergism of antihypertensive agents from different classes and improved adherence. Truly drug-resistant hypertension is commonly caused by chronic kidney disease, obstructive sleep apnea, or hyperaldosteronism, all of which can lead to fluid retention. Higher doses of diuretics (or a change to a loop diuretic) are usually needed. Other strategies include adding an alpha blocker, alpha-beta blocker, clonidine, or an aldosterone antagonist (e.g., spironolactone). Particularly in patients with diabetes or renal disease, combining a long-acting nondihydropyridine with a dihydropyridine calcium channel . blocker can also be considered. Obesity, heavy alcohol intake, high levels of dietary sodium, and interfering substances (especially nonsteroidal anti-inflammatory drugs) contribute to hypertension that is resistant or difficult to control.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19496385

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  5 in total

1.  Resistant hypertension optimal treatment trial: a randomized controlled trial.

Authors:  Eduardo M Krieger; Luciano F Drager; Dante Marcelo Artigas Giorgi; Jose Eduardo Krieger; Alexandre Costa Pereira; José Augusto Soares Barreto-Filho; Armando da Rocha Nogueira; José Geraldo Mill
Journal:  Clin Cardiol       Date:  2013-12-11       Impact factor: 2.882

2.  Chia flour supplementation reduces blood pressure in hypertensive subjects.

Authors:  Luciana Tavares Toscano; Cássia Surama Oliveira da Silva; Lydiane Tavares Toscano; Antônio Eduardo Monteiro de Almeida; Amilton da Cruz Santos; Alexandre Sérgio Silva
Journal:  Plant Foods Hum Nutr       Date:  2014-12       Impact factor: 3.921

3.  Prescribing patterns in the treatment of hypertension among underserved African American elderly.

Authors:  Hamed Yazdanshenas; Mohsen Bazargan; Gail Orum; Leila Loni; Navid Mahabadi; Baqar Husaini
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

4.  Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension.

Authors:  Dean J Kereiakes; Steven G Chrysant; Joseph L Izzo; Thomas Littlejohn; Suzanne Oparil; Michael Melino; James Lee; Victor Fernandez; Reinilde Heyrman
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-01-24       Impact factor: 3.738

5.  A Search for Secondary Hypertension: "Where's Waldo?"

Authors:  Seda Tolu; Neelja Kumar; Shitij Arora
Journal:  Cureus       Date:  2021-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.